We review the 2024 performance of both assets, the 2025 outlook, and some specific recommendations for investment in shares ...

Let's run the numbers and see how much an Australian investor would need in their superannuation fund to live off $65,000 a ...

Investing $1,000 a month with an average total return of 12% per annum would grow into $2.15 million after 27 years. That ...

Up 25% in 12 months, a leading fundie sees strong ongoing growth potential for this S&P/ASX 300 Index (ASX: XKO) stock.

Last week, the broker reaffirmed its buy rating and $40.20 price target on the ASX 200 share. This implies potential upside ...

The S&P/ASX 200 Index (ASX: XJO) is up 3% in 2025, with these three ASX 200 stocks doing a lot of the heavy lifting.

Kogan.com Ltd (ASX: KGN) and Regis Resources Ltd (ASX: RRL) are two of four ASX shares falling on Friday. Here's ...

Looking to add a few booming ASX tech shares to your portfolio in 2025 with more strong growth potential? Then you may want to run your slide rule over global sports data and analytics company ...

This S&P/ASX 300 Index (ASX: XKO) tech stock has delivered by strong returns in the last few years. Here’s why there could be ...

ASX healthcare stocks are in the green on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) currently 0.41% higher.

We reveal the forecast dividend amounts and dividend yields that analysts expect the largest ASX 200 financial shares to pay ...

Goldman has a buy rating and $40.20 price target on its shares. Another ASX 200 share that is being described as a fallen ...